Compound information
- Natural Products
- ZC1163147
- Molecular Formula
- C14H19NO4
- Molecular Weight
- 265.131408088 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-(benzyloxycarbonylamino)hexanoic acid
- InChI
- InChI=1S/C14H19NO4/c1-2-3-9-12(13(16)17)15-14(18)19-10-11-7-5-4-6-8-11/h4-8,12H,2-3,9-10H2,1H3,(H,15,18)(H,16,17)/t12-/m1/s1
- InChI Key
- NMYWMOZOCYAHNC-GFCCVEGCSA-N
- SMILES
- CCCC[C@@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000002168263
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.786 |
LogS | -3.103 | LogD | 1.87 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.011 | Pgp substrate | 0.006 |
HIA | 0.958 | F20 % | 0.996 |
F30 % | 0.939 | Caco-2 | -5.134 |
MDCK | -5.457 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.93 | PPB | 78.235 |
VD | 0.433 | Fu | 0.854 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.013 | CYP1A2 substrate | 0.562 |
CYP2A6 substrate | 0.364 | CYP2B6 substrate | 0.467 |
CYP2C19 inhibitor | 0.031 | CYP2C19 substrate | 0.481 |
CYP2C8 substrate | 0.567 | CYP2C9 inhibitor | 0.096 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.033 |
CYP2D6 substrate | 0.185 | CYP2E1 substrate | 0.371 |
CYP3A4 inhibitor | 0.03 | CYP3A4 substrate | 0.795 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.869 | CL | 1.613 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.36 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.039 |
FDAMDD | 0.036 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.007 | Eye Corrosion | 0.003 |
Eye Irritation | 0.14 | Respiratory Toxicity | 0.005 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.186 | IGC50 | 2.422 |
LC50FM | 3.654 | LC50DM | 4.318 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.382 | NR-AR-LBD | 0.306 |
NR-AhR | 0.004 | NR-Aromatase | 0.031 |
NR-ER | 0.338 | NR-ER-LBD | 0.318 |
NR-PPAR-gamma | 0.509 | SR-ARE | 0.037 |
SR-ATAD5 | 0.277 | SR-HSE | 0.077 |
SR-MMP | 0.01 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.